​

Establishment Labs (ESTA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ESTA Stock Forecast

Establishment Labs (ESTA) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $102.00, with a high of $105.00 and a low of $95.00. This represents a 34.94% increase from the last price of $75.59.

$25 $41 $57 $73 $89 $105 High: $105 Avg: $102 Low: $95 Last Closed Price: $75.59

ESTA Stock Rating

Establishment Labs stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (85.71%), 2 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 12 Strong Sell Sell Hold Buy Strong Buy

ESTA Price Target Upside V Benchmarks

TypeNameUpside
StockEstablishment Labs34.94%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks12.76%

Price Target Trends

1M3M12M
# Anlaysts4410
Avg Price Target$102.00$102.00$88.40
Last Closing Price$75.59$75.59$75.59
Upside/Downside34.94%34.94%16.95%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26261--9
Jul, 26261--9
Jun, 26261--9
May, 26261--9
Apr, 26261--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2026BTIG$103.00$79.0530.30%36.26%
Aug 06, 2026Mike MatsonNeedham$95.00$79.0520.18%25.68%
Aug 06, 2026Caitlin CroninCanaccord Genuity$105.00$79.0532.83%38.91%
Jul 15, 2026Anthony PetroneMizuho Securities$105.00$86.5921.26%38.91%
Dec 31, 2025Sam EiberBTIG$86.00$72.9217.94%13.77%
Dec 17, 2025Canaccord Genuity$85.00$74.1514.63%12.45%
Dec 10, 2025Mike MatsonNeedham$84.00$71.0118.29%11.13%
Nov 14, 2025Sam EiberBTIG$81.00$64.7525.10%7.16%
Nov 06, 2025Needham$70.00$64.917.84%-7.40%
Nov 05, 2025Sam EiberBTIG$70.00$59.5517.55%-7.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 13, 2026CitigroupNeutralBuyupgrade
Aug 07, 2026BTIGBuyBuyhold
Aug 06, 2026NeedhamBuyBuyhold
Aug 03, 2026Cowen & Co.BuyBuyhold
Jul 13, 2026BTIGBuyBuyhold
Jul 08, 2026CitigroupNeutralNeutralhold
Jun 08, 2026Cowen & Co.BuyBuyhold
May 07, 2026BTIGBuyBuyhold
May 06, 2026CitigroupNeutralNeutralhold
Dec 31, 2025BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.72$-3.08$-3.07$-3.00$-1.72---
Avg Forecast$-1.42$-3.21$-3.17$-2.42$-1.81$-1.11$0.75$2.00
High Forecast$-1.37$-3.15$-3.14$-2.23$-1.72$-0.72$0.76$2.02
Low Forecast$-1.46$-3.24$-3.19$-2.53$-1.95$-1.85$0.73$1.95
Surprise %21.13%-4.05%-3.15%23.97%-4.97%---

Revenue Forecast

$100M $190M $280M $370M $460M $550M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$126.68M$161.70M$165.15M$166.03M$211.08M---
Avg Forecast$126.30M$160.94M$164.94M$165.97M$206.54M$261.49M$389.80M$519.60M
High Forecast$128.55M$162.24M$165.11M$167.16M$207.63M$261.49M$392.60M$523.33M
Low Forecast$122.73M$158.44M$164.70M$162.91M$205.46M$261.49M$382.61M$510.02M
Surprise %0.30%0.47%0.13%0.03%2.19%---

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.14M$-75.21M$-78.50M$-84.60M$-51.06M---
Avg Forecast$-36.45M$-82.20M$-81.09M$-61.03M$-47.04M$-31.69M$19.06M$51.20M
High Forecast$-35.11M$-80.54M$-80.45M$-57.18M$-44.06M$-18.37M$19.38M$51.68M
Low Forecast$-37.29M$-83.06M$-81.72M$-64.87M$-50.02M$-47.43M$18.74M$49.97M
Surprise %12.88%-8.50%-3.19%38.62%8.55%---

ESTA Forecast FAQ

Is Establishment Labs stock a buy?

Establishment Labs stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Establishment Labs is a favorable investment for most analysts.

What is Establishment Labs's price target?

Establishment Labs's price target, set by 14 Wall Street analysts, averages $102 over the next 12 months. The price target range spans from $95 at the low end to $105 at the high end, suggesting a potential 34.94% change from the previous closing price of $75.59.

How does Establishment Labs stock forecast compare to its benchmarks?

Establishment Labs's stock forecast shows a 34.94% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (12.76%).

What is the breakdown of analyst ratings for Establishment Labs over the past three months?

  • August 2026: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.

What is Establishment Labs’s EPS forecast?

Establishment Labs's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.11, marking a -35.47% decrease from the reported $-1.72 in 2025. Estimates for the following years are $0.75 in 2027, and $2 in 2028.

What is Establishment Labs’s revenue forecast?

Establishment Labs's average annual revenue forecast for its fiscal year ending in December 2026 is $261.49M, reflecting a 23.88% increase from the reported $211.08M in 2025. The forecast for 2027 is $389.8M, and $519.6M for 2028.

What is Establishment Labs’s net income forecast?

Establishment Labs's net income forecast for the fiscal year ending in December 2026 stands at $-31.688M, representing a -37.94% decrease from the reported $-51.064M in 2025. Projections indicate $19.06M in 2027, and $51.2M in 2028.